Product
Rituxan
1 clinical trial
5 indications
Indication
Lymphomatoid GranulomatosisIndication
GranulomatosisIndication
LymphomatoidIndication
Non-Hodgkin's LymphomaIndication
lymphoproliferative disorderClinical trial
Treatment and Natural History Study of Lymphomatoid GranulomatosisStatus: Active (not recruiting), Estimated PCD: 2030-02-01